Concepedia

H. Michael Shepard

HM

Statistics

Publications

51

Citations

10.2K

H-Index

37

Active since

1978

Affiliations

Acentech (United States)(Current)

University of California, San Francisco

Cancer Research Institute

Genentech

AvidBiotics (United States)

H. Michael Shepard is an author at Acentech (United States) specializing in oncology, life sciences, and molecular oncology.

Publications per year

1978–2019

51

Publications

51

Humanization of an anti-p185HER2 antibody for human cancer therapy.

Paul Carter, Leonard G. Presta, C Gorman et al. · Proceedings of the National Academy of Sciences · 1992 · 1.9K citations

, , +16

Identification of Heregulin, a Specific Activator of p185 <sup>erbB2</sup>

William E. Holmes, Mark X. Sliwkowski, Robert W. Akita et al. · Science · 1992 · 965 citations

, , +14

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

Christopher C. Benz, Gary K. Scott, Jay Sarup et al. · Breast Cancer Research and Treatment · 1992 · 760 citations

, , +14

p185 <i> <sup>HER2</sup> </i> Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor

Robert M. Hudziak, Gail D. Lewis Phillips, Marcy Winget et al. · Molecular and Cellular Biology · 1989 · 663 citations · Full text

, , +15

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

Gail D. Lewis Phillips, Irene S. Figari, B M Fendly et al. · Cancer Immunology Immunotherapy · 1993 · 498 citations · Full text

, , +12

1–5 of 51